Exact Mass: 300.0251848
Exact Mass Matches: 300.0251848
Found 53 metabolites which its exact mass value is equals to given mass value 300.0251848,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Demethylwedelolactone
Demethylwedelolactone is a naturally occurring coumestan isolated from Eclipta alba. Demethylwedelolactone is a potent trypsin inhibitor with an IC50 of 3.0 μM. Demethylwedelolactone suppresses cell motility and cell invasion of breast cancer cell[1][2]. Demethylwedelolactone is a naturally occurring coumestan isolated from Eclipta alba. Demethylwedelolactone is a potent trypsin inhibitor with an IC50 of 3.0 μM. Demethylwedelolactone suppresses cell motility and cell invasion of breast cancer cell[1][2].
UXN2KXV8BB
Demethylwedelolactone is a member of coumestans. Demethylwedelolactone is a natural product found in Sphagneticola calendulacea, Eclipta alba, and other organisms with data available. Demethylwedelolactone is a naturally occurring coumestan isolated from Eclipta alba. Demethylwedelolactone is a potent trypsin inhibitor with an IC50 of 3.0 μM. Demethylwedelolactone suppresses cell motility and cell invasion of breast cancer cell[1][2]. Demethylwedelolactone is a naturally occurring coumestan isolated from Eclipta alba. Demethylwedelolactone is a potent trypsin inhibitor with an IC50 of 3.0 μM. Demethylwedelolactone suppresses cell motility and cell invasion of breast cancer cell[1][2].
Emodic acid
Emodicacid is a member of anthracenes.
Norwedelolactone
Demethylwedelolactone is a naturally occurring coumestan isolated from Eclipta alba. Demethylwedelolactone is a potent trypsin inhibitor with an IC50 of 3.0 μM. Demethylwedelolactone suppresses cell motility and cell invasion of breast cancer cell[1][2]. Demethylwedelolactone is a naturally occurring coumestan isolated from Eclipta alba. Demethylwedelolactone is a potent trypsin inhibitor with an IC50 of 3.0 μM. Demethylwedelolactone suppresses cell motility and cell invasion of breast cancer cell[1][2].
STA-0DC (TENTATIVE)
TENTATIVELY IDENTIFIED SPECTRUM ONLY!!!!!!!!!; BASE PEAK ARISES FROM CO-ELUTING COMPOUND!!!!!; Extracted (without noise removal) from ZUE_N: mz299_02_rt8_95_HCD60_STA-0DC; CONFIDENCE Tentative identification: best match only (Level 3)
(4-Chlorophenyl)(4-(trifluoromethoxy)phenyl)methanone
C14H8ClF3O2 (300.01648939999995)
2-chloro-N-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide
C13H8ClF3N2O (300.02772239999996)
Glycine, N-(carboxymethyl)-N-2-(carboxymethyl)aminoethyl-, trisodium salt
C8H11N2Na3O6 (300.03101860000004)
2-NITRO-1-(2-PYRIDYLTHIO)-4-(TRIFLUOROMETHYL)BENZENE
sodium,4-[2-(4-oxocyclohexa-2,5-dien-1-ylidene)hydrazinyl]benzenesulfonate
methyl 1-(3,4-dichlorophenyl)-4-oxocyclohexane-1-carboxylate
2-BENZO[1,3]DIOXOL-5-YL-6-CHLORO-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE
3-(1-(2,6-DICHLORO-3-FLUOROPHENYL)ETHOXY)PYRIDIN-2-AMINE
(R)-3-(1-(2,6-Dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine
4-phenyl-1-(trideuteriomethyl)pyridin-1-ium,iodide
2-[3-chloro-4-(trifluoromethyl)phenyl]benzoic acid
C14H8ClF3O2 (300.01648939999995)
2-(4-bromo-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
C12H15BBrFO2 (300.03324319999996)
4-CHLORO-3-(TRIFLUOROMETHYL)-[1,1-BIPHENYL]-3-CARBOXYLIC ACID
C14H8ClF3O2 (300.01648939999995)
2-Bromomethyl-4-fluorophenylboronic acid neopentyl glycol ester
C12H15BBrFO2 (300.03324319999996)
5-Bromo-2-fluorophenylboronic acid pinacol ester
C12H15BBrFO2 (300.03324319999996)
methyl (2Z,4Z)-5-chloro-2-(chloromethyl)-5-(4-methoxyphenyl)penta-2,4-dienoate
2-(2-NITROPHENYLTHIO)ISOINDOLINE-1,3-DIONE
C14H8N2O4S (300.02047680000004)
2-(1,3,4-Oxadiazol-2-yl)phenyl 4-chlorobenzenecarboxylate
6-Hydroxy-11-methyl-13-(trifluoromethyl)-8-thia-3,10-diazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),5,10,12-pentaen-4-one
5,6-Bis[(2-hydroxyethyl)sulfanyl]benzimidazole-4,7-quinone
4-[5-(2-Chlorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid
6-Oxo-1,6-dihydrodibenzo[cd,g]indazole-3-sulfonic acid
C14H8N2O4S (300.02047680000004)
An arenesulfonic acid that is 1,6-dihydrodibenzo[cd,g]indazole-3-sulfonic acid substituted by an oxo group at position 6.
2-[(2,2-dichloro-3,3-dimethylcyclopropyl)methylthio]-1H-benzimidazole
4-(5-(3-Chlorophenyl)-1,2,4-oxadiazol-3-yl)benzoic acid
N3-(4-chlorophenyl)-4-(trifluoromethyl)nicotinamide
C13H8ClF3N2O (300.02772239999996)
phosphatidylglycerol (18:2/16:1)
A phosphatidylglycerol 34:3 in which the acyl group at position 1 contains 18 carbons and two double bonds while that at position 2 contains 16 carbons and 1 double bond.
6,13-dihydroxy-5-methoxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione
(4s,7s)-4,7-bis(2-methylpropyl)-1,2,3,5,6-pentathiepane
4,6,13,14-tetrahydroxy-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1(10),2(7),3,5,11(16),12,14-heptaen-9-one
7-(methyldisulfanyl)-3-phenylcyclohepta[b]furan-2-one
(2r)-2-[(1-hydroxyethylidene)amino]-3-{[(1z)-1-(hydroxyimino)-2-phosphonoethyl]sulfanyl}propanoic acid
C7H13N2O7PS (300.01810780000005)